Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated GBCA administration effects on motor and cognitive function
NCT04373564Phase 4Recruiting
- Sponsor
- Guerbet
- Start
- Mar 2021
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 4 trial of gadolinium, sponsored by Guerbet. Started Mar 2021; status: recruiting.
02
Drugs
gadolinium
Beyond the preview
Go deeper on NCT04373564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04373564.